ANTIOXIDANT AND CHOLINESTERASE INHIBITORY ACTIVITY OF GREWIA HIRSUTA VAHL. LEAVES
HTML Full TextANTIOXIDANT AND CHOLINESTERASE INHIBITORY ACTIVITY OF GREWIA HIRSUTA VAHL. LEAVES
V. Chikkamath *, V. H. Kulkarni, P. V. Habbu, A. N. Nagappa and G. M. Sindhu
Department of Pharmacology, S. C. S. College of Pharmacy, Harapanahalli, Karnataka, India.
ABSTRACT: Objectives: Grewia hirsuta Vahl. is a shrub explored for medicinal applications. It has anti ageing, boosting immunity, prevents loss and grey hair etc. Ethnopharmacological data suggests that the plant is extensively used as a nerve tonic and to enhance the cognitive properties. The basis of these medicinal uses seems to be antioxidant and anti cholinesterase activity. In order to establish the scientific basis between medicinal uses and its mechanism of action, antioxidant and anti cholinesterase activity investigations were carried out. Methods: Evaluation of free radical scavenging and anti cholinesterase activity was carried out using DPPH (1, 1- diphenyl-2-picryl hydrazyl), hydroxyl radical scavenging and ferric reducing method using ascorbic acid as a standard. Cholinesterase inhibitory potentials were measured by Ellman’s method against Rivastigmine. Results: The inhibitory concentration of hydro ethanolic extract of Grewia hirsuta (HEEGH) (IC50 27.25) in DPPH. In reducing power assay (IC50 65.32) and Hydrogen peroxide scavenging activity (IC50 98.28). The inhibitor concentration of acetylcholinesterase by standard (Rivastigmine) was (IC50 14.40μg/ml), and the extract was (IC50 133.4μg/ml), whereas, butyrylcholinesterase (IC50 96.46μg/ml). Conclusion: HEEGH possesses the significant concentration-dependent inhibitory action as an antioxidant and anti acetyl cholinesterase and butyrylcholinesterase activity. This activity might be due to the presence of phenols, flavonoids, tannins and specific amino acids in significant amount.
Keywords: Free radicals, Antioxidant, Acetylcholinesterase, Butyrylcholinesterase, Alzheimer’s disease
INTRODUCTION: The use of herbal medicine as an antioxidant is an interesting research, as synthetic drugs fall short of resolving the oxidative stress. Oxidative stress is a root cause of manifestation of many diseases like Diabetes (type 1 & 2), Cancer, Alzheimer’s, Asthma etc 1.
The free radicals are produced in the body by the electron chain reaction, when glucose is used to make energy. The oxygen molecule (O2) is split into two singlet oxygen atoms; one of the singlet oxygen’s is used in the mitochondria to carry out phosphorylation and subsequent energy production.
The other singlet oxygen is a free radical and is capable of damaging of vital biomolecules like proteins and nucleic acid. Naturally glutathione and other antioxidant molecules are present which scavenge the released free radical and prevent the formation of free radicals 2. In case, free radical of proteins and nucleic acids go uninterrupted by antioxidants, this will lead to damage of proteins and nucleic acids rendering them non-functional. In order to prevent and protect the oxidative stress there should be adequate antioxidant molecules. The imbalance of free radicals and antioxidants result in the manifestation of the diseases like diabetes, cancer, cell aging etc 3. It is logical to supplement antioxidant when natural antioxidant falls short of body requirement. Antioxidant supplements include vitamin C, vitamin E, beta-carotene, and other related carotenoids, along with the minerals selenium and manganese. The short & long-term memory is attributed to cholinergic transmission in the brain. The free radical generated in the system gets neutralized when it meets an appropriate antioxidant.
Naturally occurring antioxidants like glutathione and other antioxidant molecules usually take care and offer neuro protection on the oxidative stress condition 4. If the naturally occurring antioxidants are over powered by natural antioxidants is the oxidative stress over powers antioxidant present in the system. The free radicals come, out and a chain reaction happens leading to widespread conversation of free radical molecules in and around the biomolecules in the neuron is rendered functionless when they convert into free radicals. The major cause of cholinesterase enzyme which was rendered functionless leads to high concentrations of acetyl choline. Thus, leading to damage of neuronal damage of cholinergic neurons 5.
Grewia hirsuta Vahl. is very popular in folklore and Ayurveda as Nagabala. It is a shrub grown up to 1 meter tall, leaves are simple and soft arranged alternately. Flowers are white in color and turn to brown when dried. It is found in India, Bangladesh, Srilanka etc. It contains proline, phenylalanine, isoleucine, lysine, glutamic acid, serine and beta sitosterol as phytoconstituents significantly. Root is used to increase sperm count and quality in Ayurveda and Siddha system of medicines. Root is also used to treat heart diseases, controls high blood pressure and in the early stages of tuberculosis. Leaves and fruits are used as expectorants, carminative, abortifacient, and galactagogue. It is also used in splenic enlargement, piles, rheumatism pain in joints and in the breasts 6. Variety of properties and uses creates curiosity to further explore scientifically and find out the secrete for its genesis of pharmacological and therapeutic applications. In the literature, there is mention of strong antioxidant properties which were reported by Varsha Hutke et al, 2002 7. As it finds application in ENT there is every reason of involvement of parasympathetic apparatus. So, it was decided to its enzyme inhibition like acetyl cholinesterase and butryl cholinestrase activity 6.
MATERIALS AND METHODS: The leaves of Grewia hirsuta vahl. collected from surroundings of Chittoor, Andra Pradesh. The identification and authentication was done by Dr. K. Madhava Chetty, Plant taxonomist (IAAT: 357) belonging to Sri Venkateswara University, Tirupati, Andhra Pradesh. The shade dried leaves were extracted by continuous hot extraction method 8.
Reagents and Chemicals: The reagents and chemicals of analytical grade were used.
In-vitro Antioxidant Activity:
DPPH Radical Scavenging Assay: DPPH (1, 1- diphenyl-2-picryl hydrazyl) a hydrogen donor was prepared in methanol (1mg/ml). HEEGH were added in the serial dilution of (10, 20,40,60,80 & 100µg/ml). After allowing reaction time of 30 minutes, the optical density was measured at 517 nm and standard curve of ascorbic acid (water soluble hydrogen acceptor) is plotted for estimating the concentration of antioxidant principle of the plant 9-10.
Reducing Power Assay: The reducing power of HEEGH was determined according to method of Oyaizu (Oyaizu, 1986). Aliquots of HEEGH were mixed serial dilutions from 10μg to 100μg/ml. The optical density was measured at 700nm and the concentration was measured by using standard curve ascorbic acid 11-12.
Hydrogen Peroxide Scavenging (H2O2) Activity: The scavenging activity of hydrogen peroxide of HEEGH was estimated as described by Keser S et al 14. Briefly, 2ml of HEEGH solution (100μ-600μg/ml) in methanol was added to 4ml of hydrogen peroxide (20 mM) solution in phosphate buffer (PH 7.4). After 10min, the absorbance was measured at 230nm against phosphate buffer blank solution 13-14.
In-vitro Acetyl cholinesterase and Butryl Cholinesterase Inhibition 15: The cholinesterase inhibitor activity of the HEEGH was measured as per Ellman’s method. Rivastigmine was used as a positive control for both enzymes. The enzyme inhibition (%) was calculated as follows:
% Inhibition = (A0−A1) / (A0) × 100
Where, A0 = Absorbance of control; A1 = Absorbance of extract/ standard.
RESULTS:
In-vitro DPPH Free Radical Scavenging Activity: The results indicate both in the standard and HEEGH shows DPPH free radical scavenging activity is dependent of concentration. The percentage of inhibition of standard ranges from 42.24% - 82.25%, HEEGH 28.44%-80.33%. The inhibitory concentration of ascorbic acid (IC50 20.14) and HEEGH (IC50 27.25). All the readings were an average of triplicate sample. (See Table 1).
TABLE 1: EFFECT OF HEEGH ON PERCENTAGE INHIBITION OF DPPH
Sl. no. | Concentration (µg/ml) | Standard (Ascorbic acid) | HEEGH |
Percentage inhibition | Percentage inhibition | ||
1. | 10 | 42.24 | 28.44 |
2. | 20 | 46.16 | 37.22 |
3. | 40 | 62.32 | 59.17 |
4. | 60 | 68.42 | 65.43 |
5. | 80 | 74.68 | 70.54 |
6. | 100 | 82.25 | 80.33 |
IC 50 (µg/ml) | 20.14 | 27.25 |
Reducing Power Activity using Potassium Ferricyanide: The results were given in Table 2. The results indicate both in the standard and sample shows reducing power activity dependent of concentration. The percentage inhibition of standard ranges from 38.43-73.68% & HEEGH 18.04% - 58.53%. All the readings were an average of triplicate of sample. The inhibitor concentration ascorbic acid (IC50 31.54) and HEEGH (IC50 65.32).
TABLE 2: EFFECT OF HEEGH ON PERCENTAGE INHIBITION IN REDUCING POWER ASSAY
Sl. no. | Concentration (µg/ml) | Standard (Ascorbic acid) | HEEGH |
Percentage inhibition | Percentage inhibition | ||
1. | 10 | 38.43 | 18.04 |
2. | 20 | 44.28 | 24.52 |
3. | 40 | 53.22 | 34.43 |
4. | 60 | 58.19 | 42.86 |
5. | 80 | 61.54 | 49.60 |
6. | 100 | 73.68 | 58.53 |
IC 50 (µg/ml) | 31.54 | 65.32 |
Hydrogen Peroxide Scavenging (H2O2) Assay: In this assay also both in the standard and test extract shows hydrogen peroxide radical scavenging activity is dependent of concentration. The percentage of inhibition of standard ranges from 2.45% - 65.15%, & HEEGH 1.02% - 45.20%. The inhibitor concentration ascorbic acid (IC50 36.16) and HEEGH (IC50 98.28). All the readings were an average of triplicate sample (See Table 3).
TABLE 3: EFFECT OF HEEGH ON HYDROXYL RADICAL SCAVENGING ACTIVITY
Sl. no. | Concentration (µg/ml) | Standard (Ascorbic acid) | HEEGH |
Percentage inhibition | Percentage inhibition | ||
1. | 100 | 2.45% | 1.02% |
2. | 200 | 4.98% | 2.85% |
3. | 300 | 14.25% | 6.15% |
4. | 400 | 33.44% | 29.68% |
5. | 500 | 45.68% | 32.17% |
6. | 600 | 65.15% | 45.20% |
IC 50 (µg/ml) | 36.16 | 98.28 |
In-vitro Acetylcholinesterase and Butryl-cholinestrase Activity: Anti acetylcholinesterase and butrylcholinestrase activity by Elman’s method. The standard curve was plotted against concentration versus percentage inhibition. The HEEGH concentration shows increased inhibition of enzyme activity similarly the standard curve. (See Table 4 and Fig. 1 & 2).
TABLE 4: PERCENTAGE INHIBITION OF HEEGH AND RIVASTIGMINE ON CHOLINESTERASE
Acetylcholinesterase Activity | Butrylcholinesterase Activity | |||
Concentration
(μg/ml) |
Percentage inhibition of HEEGH | Percentage inhibition of Rivastigmine | Percentage inhibition of HEEGH | Percentage inhibition of Rivastigmine |
Control | 0.00 | 0.00 | 0.00 | 0.00 |
20 | 10.03 | 61.25 | 3.29 | 60.47 |
40 | 16.96 | 70.42 | 17.44 | 72.09 |
60 | 23.18 | 80.62 | 27.52 | 80.43 |
80 | 30.62 | 84.95 | 41.47 | 85.27 |
100 | 43.77 | 92.91 | 51.74 | 94.38 |
IC 50 (µg/ml) | 133.4 | 96.46 | 14.40 |
FIG. 1: ACHE & BCHE INHIBITION ACTIVITY COMPARISON OF HEEGH AND RIVASTIGMINE
FIG. 2: EFFECT OF HEEGH ON IC50 CHOLINESTERASE INHIBITION ACTIVITY
DISCUSSION: Oxidative stress and memory impairment are commonly observed among adults and elderly impairing the quality of life. Oxidative stress disturbs the milieu interieur. Acetylcholine is responsible for quality neurotransmission which is important for short and long term memory. The synthetic drugs available include ascorbic acid and tocopherol for an antioxidant activity, whereas; rivastigmine, galantamine, piracetam etc. are as Nootropics 16. In this paper, we have compared the antioxidant activity by DPPH, reducing power antioxidant assay and hydrogen peroxide assay method. The results indicate that HEEGH has comparable the antioxidant and nootropic activity. The limitation of the study is in-vitro methods and further evaluation should be done on animal models and clinical studies. One of the strong evidence is from ethnopharmacological uses of Grewia hirsuta reference by traditional healers.
CONCLUSION: There is a need for herbal options in the treatment of oxidative stress and neurodegenerative diseases. Hence, this research proves an alternative antioxidant and nootropic drugs for synthetic drugs. Synthetic drugs are having well established side effects which mandates for Pharmacovigilance studies. Grewia hirsuta has been in use time immemorial and may not manifest severe toxicity effects like synthetic drugs.
ACKNOWLEDGEMENTS: The authors thank the Management and Principal of S. C. S College of Pharmacy Harapanahalli and S.E.T’s College of Pharmacy, Dharwad for providing all necessary facilities to carry out research work.
Financial Support and Sponsorship: Nil
CONFLICTS OF INTEREST: There are no conflicts of interest.
REFERENCES:
- Sankaran BG, Nari S, Admuthe BN, Madhab M, Vasudha K and Sreenivas A: The role of herbal medicine in oxidative stress: prevention of diabetes. International Journal of Membrane Science and Technology 2023; (10)4: 2374-2378.
- Martemucci G, Costagliola C, Mariano M, D’andrea L and Napolitano P: D’Alessandro A Free Radical Properties, Source and Targets, Antioxidant Consumption and Health. Oxygen 2022; 2: 48–78.
- Chaudhary P, Janmeda P, Docea AO, Yeskaliyeva B, Abdull Razis AF and Modu B: Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases. Frontiers in Chemistry 2023; 11-24.
- Available from: https://www.ncbi.nlm.nih.gov/books/NBK225471 accessed on [18/2/2024].
- Martemucci G, Costagliola C, Mariano M, D’andrea L, Napolitano PD and Alessandro AG: Free radical properties source and targets antioxidant consumption and health oxygen 2022; 2: 48-78.
- Chikkamath V, Kulkarni VH, Habbu PV and Kulkarni PV: Grewia hirsuta vahl chemical constituents and biological activities. RGUHS Journal of Pharmaceutical sciences. 2019; 9(3): 3-10.
- Hutke VD and Naswale M: Screening of various extracts of Grewia hirsuta leaves and fruits for secondary metabolites. Journal of Medicinal Plants Research 2017; 5(1): 323-325.
- Kokate CK: Practical Pharmacognosy. 4th ed. Delhi: Vallabh Prakashan 1994; 123-5.
- Baliyan S, Mukherjee R, Priyadarshini A, Vibhuti A, Gupta A and Pandey RP: Determination of antioxidants by DPPH radical scavenging activity and quantitative phytochemical analysis of Ficus religiosa. Molecules 2022; 27(4): 1326: 1-19.
- EL Babili F, Nigon C, Lacaze L, Mille J, Masiala A and Simm J: A new colorimetric DPPH radical scavenging activity method: comparison with spectrophotometric assay in some medicinal plants used in moroccan pharmacopoeia. Pharmaceutical Fronts 2022; 4(2): 89-102.
- Kedir WM, Geletu AK, Weldegirum GS and Sima MF: Antioxidant activity of selected plants extract for palm oil stability via accelerated and deep frying study. Heliyon 2023; 9: 1-16.
- Seon HY, Jeon SH and Yim SH: Puerariae Flos extracts possess the potential antioxidant efficacy against oxidant stress. Food Science and Technology 2022; 42: 1-7.
- Hussen EM and Endalew SA: In-vitro antioxidant and free-radical scavenging activities of polar leaf extracts of Vernonia amygdalina. BMC Complementary Medicine and Therapies 2023; 23(146): 1-12.
- Ramasamy A, Anandakumar K and Kathiresan K: In-vitro antioxidant potential and acetylcholinesterase inhibitory effect of Ficus benghalensis aerial root extract. African Health Sciences 2022; 22(4): 291–299.
- Imran I, Javaid S, Waheed A, Rasool MF, Majeed A and Samad N: Grewia asiatica berry Juice diminishes anxiety, depression and scopolamine-induced learning and memory impairment in behavioral in experimental animal models. Frontiers in Nutrition 2021; 7: 1-19.
- Padmanabh Singh P, Barman B and Thakur MK: Oxidative stress-mediated memory impairment during aging and its therapeutic intervention by natural bioactive compounds. Frontiers in Aging Neuroscien 2022; 14: 1-14.
How to cite this article:
Chikkamath V, Kulkarni VH, Habbu PV, Nagappa AN and Sindhu GM: Antioxidant and cholinesterase inhibitory activity of Grewia hirsuta Vahl. leaves. Int J Pharm Sci & Res 2024; 15(8): 2495-99. doi: 10.13040/IJPSR.0975-8232.15(8).2495-99.
All © 2024 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
37
2495-2499
556 KB
48
English
IJPSR
V. Chikkamath *, V. H. Kulkarni, P. V. Habbu, A. N. Nagappa and G. M. Sindhu
Department of Pharmacology, S. C. S. College of Pharmacy, Harapanahalli, Karnataka, India.
vinuth6288@gmail.com
09 March 2024
09 April 2024
24 April 2024
10.13040/IJPSR.0975-8232.15(8).2495-99
01 August 2024